OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment
Huang Chen, Aiwu Bian, Wenbo Zhou, et al.
ACS Central Science (2024) Vol. 10, Iss. 3, pp. 579-594
Open Access | Times Cited: 11
Huang Chen, Aiwu Bian, Wenbo Zhou, et al.
ACS Central Science (2024) Vol. 10, Iss. 3, pp. 579-594
Open Access | Times Cited: 11
Showing 11 citing articles:
Synergistic Delivery of Paclitaxel-Coated ZIF-8 Metal-Organic Framework Nanoparticles for Enhanced in Vitro Administration in Liver Cancer Cell Lines
Xinhua Zhao, Xiaoyong Wu, Liqin Ruan, et al.
Journal of Cluster Science (2025) Vol. 36, Iss. 2
Closed Access
Xinhua Zhao, Xiaoyong Wu, Liqin Ruan, et al.
Journal of Cluster Science (2025) Vol. 36, Iss. 2
Closed Access
Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level
Lidan Zhang, Pingxian Liu, Yunhan Jiang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116448-116448
Closed Access | Times Cited: 3
Lidan Zhang, Pingxian Liu, Yunhan Jiang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116448-116448
Closed Access | Times Cited: 3
Nature’s Arsenal: Harnessing the Capacity of Phytochemicals to Enhance Immune Checkpoint Inhibitor Therapy of Cancers: An Especial Attention to Brain Malignancies
Amir R. Afshari, Mehdi Sanati, Seyed Sajad Ahmadi, et al.
Cancer Letters (2024) Vol. 593, pp. 216955-216955
Closed Access | Times Cited: 3
Amir R. Afshari, Mehdi Sanati, Seyed Sajad Ahmadi, et al.
Cancer Letters (2024) Vol. 593, pp. 216955-216955
Closed Access | Times Cited: 3
Design, synthesis and biological evaluation of novel naphthoquinothiazole derivatives as potent antitumor agents through inhibiting STAT3
Dongmei Fan, Pingxian Liu, Z.-Q. Li, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107565-107565
Closed Access | Times Cited: 2
Dongmei Fan, Pingxian Liu, Z.-Q. Li, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107565-107565
Closed Access | Times Cited: 2
Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy
Dandan Shi, Jiejing Tao, Shuli Man, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189207-189207
Closed Access | Times Cited: 2
Dandan Shi, Jiejing Tao, Shuli Man, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189207-189207
Closed Access | Times Cited: 2
Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024)
Zhaoyong Kang, Li Shen, Yan Li, et al.
Chinese Chemical Letters (2024), pp. 110447-110447
Closed Access | Times Cited: 1
Zhaoyong Kang, Li Shen, Yan Li, et al.
Chinese Chemical Letters (2024), pp. 110447-110447
Closed Access | Times Cited: 1
Exploring the underlying mechanisms of Danshen-Shanzha Decoction on Coronary Heart Disease: An integrated analysis combining pharmacoinformatics and experimental validation
Feng Tian, Qiong Xu, Zhe Yu, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118779-118779
Closed Access
Feng Tian, Qiong Xu, Zhe Yu, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118779-118779
Closed Access
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR
Song Han, Gerik W. Tushoski-Alemán, Peiyi Zhang, et al.
Neoplasia (2024) Vol. 59, pp. 101070-101070
Closed Access
Song Han, Gerik W. Tushoski-Alemán, Peiyi Zhang, et al.
Neoplasia (2024) Vol. 59, pp. 101070-101070
Closed Access
Design, synthesis, and biological evaluation of novel (E)-2-cyano-3-(4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-yl) derivatives as potent STAT3-targeting anticolorectal cancer agents
Weiqing Jiang, Pingxian Liu, Zhangxun Zhao, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107955-107955
Closed Access
Weiqing Jiang, Pingxian Liu, Zhangxun Zhao, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107955-107955
Closed Access
Acquired resistance to tyrosine kinase targeted therapy: mechanism and tackling strategies
Defa Wu, Qian Sun, Hongjun Tang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101176-101176
Closed Access
Defa Wu, Qian Sun, Hongjun Tang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101176-101176
Closed Access
Study on the inhibition of non-small cell lung cancer mediated by chitosan-based gene carrier delivering STAT3-shRNA
Wangwang Zhang, Liqiang Song, Yi Zhou, et al.
International Journal of Biological Macromolecules (2024) Vol. 284, pp. 138211-138211
Open Access
Wangwang Zhang, Liqiang Song, Yi Zhou, et al.
International Journal of Biological Macromolecules (2024) Vol. 284, pp. 138211-138211
Open Access
Identification of STAT3 phosphorylation inhibitors using generative deep learning, virtual screening, molecular dynamics simulations, and biological evaluation for non-small cell lung cancer therapy
Weiji Cai, Beier Jiang, Yichen Yin, et al.
Molecular Diversity (2024)
Open Access
Weiji Cai, Beier Jiang, Yichen Yin, et al.
Molecular Diversity (2024)
Open Access
